MedPath

NATIONAL JEWISH HEALTH

🇺🇸United States
Ownership
-
Established
1899-01-01
Employees
-
Market Cap
-
Website
http://www.nationaljewish.org/

Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Phase 2
Conditions
Asthma
Interventions
First Posted Date
2017-01-05
Last Posted Date
2021-03-08
Lead Sponsor
National Jewish Health
Target Recruit Count
10
Registration Number
NCT03010436
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Phase 2
Conditions
Asthma
Interventions
First Posted Date
2016-10-28
Last Posted Date
2017-09-14
Lead Sponsor
National Jewish Health
Target Recruit Count
10
Registration Number
NCT02947945
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy

Phase 4
Completed
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2016-09-29
Last Posted Date
2023-04-21
Lead Sponsor
National Jewish Health
Target Recruit Count
51
Registration Number
NCT02918409
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

The Role of Bacterial Toxins in Human Skin Disease

Conditions
Atopic Dermatitis
Psoriasis
First Posted Date
2016-09-22
Last Posted Date
2021-10-19
Lead Sponsor
National Jewish Health
Target Recruit Count
100
Registration Number
NCT02910791
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation

Phase 2
Completed
Conditions
Hypnotic Dependence Among Those With Insomnia
Interventions
Drug: 0% Hypnotic Medication Taper
Drug: 25% Hypnotic Medication Taper
Drug: 10% Hypnotic Medication Taper
First Posted Date
2016-07-13
Last Posted Date
2019-10-30
Lead Sponsor
National Jewish Health
Target Recruit Count
74
Registration Number
NCT02831894
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

The Breathe Well Program for Adults With Asthma

Not Applicable
Completed
Conditions
Asthma
Interventions
Behavioral: Email
Behavioral: IVR call/text
First Posted Date
2016-05-04
Last Posted Date
2023-11-09
Lead Sponsor
National Jewish Health
Target Recruit Count
14978
Registration Number
NCT02761837
Locations
🇺🇸

Kaiser Permanente of Colorado, Denver, Colorado, United States

Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma

Phase 2
Completed
Conditions
Corticosteroid Resistant (CR) Asthmatics
Interventions
First Posted Date
2016-04-28
Last Posted Date
2019-08-21
Lead Sponsor
National Jewish Health
Target Recruit Count
2
Registration Number
NCT02753764
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

Colorado Marijuana Users Health Cohort

Conditions
COPD
Insomnia
Cannabis
Interventions
Other: Marijuana
First Posted Date
2016-04-13
Last Posted Date
2019-03-13
Lead Sponsor
National Jewish Health
Target Recruit Count
2000
Registration Number
NCT02735954
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

Pneumococcal Post-Vaccination Titers

Not Applicable
Conditions
Smokers, Elderly, Asthma, COPD, Recurrent Infections
Interventions
Biological: PPV-23
First Posted Date
2016-04-01
Last Posted Date
2017-09-14
Lead Sponsor
National Jewish Health
Target Recruit Count
140
Registration Number
NCT02726347
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency

Conditions
Alpha 1-Antitrypsin Deficiency
First Posted Date
2016-02-25
Last Posted Date
2019-03-13
Lead Sponsor
National Jewish Health
Target Recruit Count
39
Registration Number
NCT02691611
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath